Savara Pharmaceuticals
SVRA
#6617
Rank
HK$4.29 B
Marketcap
HK$25.02
Share price
-1.23%
Change (1 day)
-30.29%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$0.30 Billion

According to Savara Pharmaceuticals's latest financial reports the company's total liabilities are HK$0.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Savara Pharmaceuticals - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$0.29 B16.18%
2022-12-31HK$0.25 B-0.11%
2021-12-31HK$0.25 B-3.22%
2020-12-31HK$0.25 B-3.76%
2019-12-31HK$0.26 B-22.13%
2018-12-31HK$0.34 B9.55%
2017-12-31HK$0.31 B-37.32%
2016-12-31HK$0.50 B113.8%
2015-12-31HK$0.23 B155.92%
2014-12-31HK$91.85 M59.17%
2013-12-31HK$57.7 M43.74%
2012-12-31HK$40.14 M1.8%
2011-12-31HK$39.43 M181.31%
2010-12-31HK$14.01 M-23.18%
2009-12-31HK$18.24 M-49.9%
2008-12-31HK$36.42 M33.22%
2007-12-31HK$27.34 M41.53%
2006-12-31HK$19.32 M-92.08%
2005-12-31HK$0.24 B2475.35%
2004-12-31HK$9.46 M649.21%
2003-12-31HK$1.26 M-83.52%
2002-12-31HK$7.66 M7.28%
2001-12-31HK$7.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$94.46 M-69.20%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.62 B 2,060.45%๐Ÿ‡บ๐Ÿ‡ธ USA